I read post #59 twice before replying, because I had assumed the opposite.
Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
10 likes 2mo
Access · Insurance & coverage · continued
An appeal that succeeded, with the letter structure — the long version posts 61–90
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
a.kowalski, post #31: Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist but many people qualify. Go to post
This follows post #59 rather than contradicting it.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
DKwiatkowski, post #18: Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected you is understandable but does not move the needle in appeals. Go to post
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist but many people qualify.
22 likes 2mo
b.jankowiak, post #26: This follows post #23 rather than contradicting it. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and responding point-by-point to it works better than general appeals. Go to post
Picking up post #63: that is the part I would want checked first.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and appeals based on the covered indication work better.
31 likes 2mo
z.nakamura, post #64: Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist but many people qualify. Go to post
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
g.radich, post #50: Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist but many people qualify. Go to post
Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
On post #68 — agreed on the reasoning, with one qualification.
Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and responding point-by-point to it works better than general appeals.
1 like 2mo
slow_titrator, post #22: Picking up post #19: that is the part I would want checked first. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration. Go to post
I disagree with the reply above, and I think the disagreement is substantive rather than terminological.
The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.
f.abrahamsen, post #39: post #38 is right about the mechanism and I think understates the practical bit. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and responding point-by-point to it works better than general appeals. Go to post
Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected you is understandable but does not move the needle in appeals.
Worth separating two things that post #72 runs together.
Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected you is understandable but does not move the needle in appeals.
3 likes 2mo
Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist but many people qualify.
17 likes 2mo
s.kimani, post #33: This follows post #30 rather than contradicting it. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration. Go to post
Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying it.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
25 likes 2mo
Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and appeals based on the covered indication work better.
0 likes 2mo
s.kimani, post #33: This follows post #30 rather than contradicting it. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration. Go to post
On post #77 — agreed on the reasoning, with one qualification.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
taper_file, post #16: I read post #14 twice before replying, because I had assumed the opposite. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying it. Go to post
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want. Understanding the requirements before treatment starts matters.
0 likes 2mo
Worth separating two things that post #81 runs together.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
6 likes 2mo
j.mwangi, post #7: Worth separating two things that post #3 runs together. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected you is understandable but does not move the needle in appeals. Go to post
post #85 is right about the mechanism and I think understates the practical bit.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
m.strand_rph, post #36: On post #32 — agreed on the reasoning, with one qualification. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift. Go to post
post #89 answers the question as asked. The question underneath it is different.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.